MD Anderson Cancer Center broke ground on a new 470,000-square-foot facility in Sugar Land

Sugar Land will bring a range of cancer services and MD Anderson’s unparalleled patient experience closer to those living in Southwest Houston and the surrounding areas.

Anticipated to open in 2029, the five-story location will be MD Anderson’s largest Houston-area location to date.

The facility will broaden services available at MD Anderson’s current Sugar Land location to include a new ambulatory surgery center, as well as expanded diagnostic imaging, radiation oncology and outpatient procedural services.

The new location also will include space for multidisciplinary clinics, supporting comprehensive cancer care for adult patients with cancer diagnoses and low-to-medium acuity needs.

“As we advance our mission to end cancer, we have an unwavering commitment to provide high-quality, compassionate care and cutting-edge treatments to every patient who walks through our doors.

By expanding our reach in Sugar Land, we can better meet the needs of patients in Southwest Houston, making it easier for them to access the treatment and support they deserve, right in their own community.” – said Peter WT Pisters, M.D., president of MD Anderson.

MD Anderson provides a variety of care options at six locations beyond the Texas Medical Center Campus. The new location will replace MD Anderson’s current leased space at 1327 Lake Pointe Parkway.

As Sugar Land and the surrounding community is one of Texas’ fastest growing suburban areas, expected to increase in population by more than 30% by 2030, the facility also will offer capacity for future growth to meet increasing demand.

“This facility comes at a pivotal moment as we strive to continue meeting the needs of our patients across Houston.

This not only will help make our care more convenient for local patients, especially those undergoing frequent treatments like chemotherapy or radiation, but it also will help increase access to care outside of our Texas Medical Center Campus, potentially decreasing wait times for both local and regional patients.” –  said Rosanna Morris, senior vice president and chief operating officer at MD Anderson.

The Sugar Land facility will support MD Anderson’s sustainability goals through a design that will reduce energy consumption, optimize natural daylight, and minimize glare and heat gain.

Thoughtfully designed with access to nature and outdoor spaces, the building will prioritize the experience of both patients and employees, reinforcing MD Anderson’s commitment to creating a healing and supportive environment.

Additionally, the Sugar Land Campus will feature a multisensory art environment aimed at inspiring hope, uplifting spirits and promoting healing for cancer patients, their families and employees. This unique art experience will be integrated from the outset of construction, with close collaboration between architects and clinical experts to ensure a holistic and impactful environment.

“This new facility is a testament to our commitment to advancing exceptional patient care and to meeting the growing needs of our community.

With its state-of-the-art design and focus on sustainability, this building will play a key role in enhancing the patient experience and supporting our mission to provide the highest quality care.” – said Kent Postma, vice president of clinical infrastructure development and growth at MD Anderson.

Further Reading:

Surgery may not be necessary to treat invasive breast cancer

MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening

The University of Texas MD Anderson Cancer Center and Myriad Genetics have announced a five-year strategic alliance

Celebrating 50 Years of Excellence: UT Health San Antonio MD Anderson Cancer Center